Karyopharm Therapeutics

Last Updated 2021-08-03
  • Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
  • Locations

    • Natick MA
  • Total Funding (USD)

    67.2 million
  • Industries

    Software, Mobile Apps
  • Security

    Type: ORD
    CUSIP: 48576U106
    ISIN: US48576U1060
Filter date
Bookmark Created by Last updated
There were no results found.
Filter date
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.